CoChat

Advancing genome-based precision medicine: a review on machine learning applications for rare genetic disorders

Open access
Abbas, Syed Raza, Abbas, Zeeshan, Zahir, Arifa, Lee, Seung Won · 2025 · Briefings in Bioinformatics

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

Abstract

Precision medicine tailors medical procedures to individual genetic overviews and offers transformative solutions for rare genetic conditions. Machine learning (ML) has enhanced genome-based precision medicine (GBPM) by enabling accurate diagnoses, customized treatments, and risk assessments. ML tools, including deep learning and ensemble methods, process high-dimensional genomic data and reveal discoveries in rare diseases. This review analyzes the ML applications in GBPM, emphasizing its role in disease classification, therapeutic optimization, and biomarker discovery. Key challenges, such as computational complexity, data scarcity, and ethical concerns, are discussed alongside advancements such as hybrid ML models and real-time genomic analysis. Security issues, including data breaches and ethical challenges, are addressed. This review identifies future directions, emphasizing the need for comprehensible ML models, increasing data-sharing frameworks, and global collaborations. By integrating the current research, this study provides a comprehensive perspective on the use of ML for rare genetic disorders, paving the way for transformative advancements in precision medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bbaf329

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Relative importance of key thematic areas in ML applications to GBPM (2023–2024).
Figure 1 Relative importance of key thematic areas in ML applications to GBPM (2023–2024).CC BY · PubMed Central
Figure 2 A theoretical representation of CRISPR gene editing utilizing ML computational model.
Figure 2 A theoretical representation of CRISPR gene editing utilizing ML computational model.CC BY · PubMed Central
Figure 3 Workflow diagram for the systematic review methodology.
Figure 3 Workflow diagram for the systematic review methodology.CC BY · PubMed Central
Figure 4 Annual publication trends (2015–2024) in ML applications for GBPM in rare genetic disorders.
Figure 4 Annual publication trends (2015–2024) in ML applications for GBPM in rare genetic disorders.CC BY · PubMed Central
Figure 5 Proportional focus on genomic data security challenges.
Figure 5 Proportional focus on genomic data security challenges.CC BY · PubMed Central
Figure 6 Importance of mitigation strategies in genomic ML security.
Figure 6 Importance of mitigation strategies in genomic ML security.CC BY · PubMed Central
Figure 7 Impacts of technologies on different aspects in precision medicine.
Figure 7 Impacts of technologies on different aspects in precision medicine.CC BY · PubMed Central
Figure 8 Comparison of current focus and future potential.
Figure 8 Comparison of current focus and future potential.CC BY · PubMed Central
Figure 9 Emphasizing total contributions across categories.
Figure 9 Emphasizing total contributions across categories.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 22

  1. Global Cybersecurity Network, 2024, Cyber security of genomic data
  2. Mitta, 2023, Machine learning for personalized medicine: tailoring treatment strategies based on individual patient data, Hong Kong J AI Med, 3, 49
  3. Ogunsakin, Leveraging ai for healthcare administration: streamlining operations and reducing costs, IRE Journals, 7
  4. Nadella, 2023, A systematic literature review of advancements, challenges and future directions of ai and ML in healthcare, Int J Mach Learn Sustain Dev, 5, 115
  5. CRISPR Medicine News, 2024, OpenCRISPR-1: Generative AI Meets CRISPR
  6. SciTech Daily, 2024, Creme: A New Ai-Powered Virtual Lab to Help Cure Genetic Diseases
  7. Australian, 2024, Rare Diseases Receive Huge Genomics Boost
  8. Deshmukh, 2024, Reinforcement learning in healthcare: applications for personalized treatment planning and clinical decision support, Shodh Sagar J Artif Intell Mach Learn, 1, 19
  9. Trust, 2024, Data and Diversity in Genomics: A Global Landscaping Report
  10. Wellcome Trust, 2024, Data and Diversity in Genomics: Landscaping Report
  11. Yaghi, 2024, Genetic Data in Jeopardy: Unraveling the Details of the Aftermath of 23andMe Hack
  12. Blum, 2024, When Hospital Ransomware Attacks Threaten Patient Safety: A New Trend to Follow
  13. Compagnucci, 2024, A multidisciplinary perspective on cross-border health data transfers, Forthcoming
  14. Pulivarti, 2023, Cybersecurity of genomic data
  15. Borfitz, 2024, AI System for Diagnosing Rare Diseases and Solving Medical Cold Cases
  16. National Human Genome Research Institute, 2021, Nhgri machine learning in genomics workshop: tools, resources, clinical applications, and ethics, Exec Sum
  17. Whole-genome alignment, 2023, Methods, challenges, and future directions. MDPI, Appl Sci, 14, 4837
  18. Tutorials, 2023, Mining Massive Biological Datasets for New Discoveries with Scalable Algorithms
  19. Joly, 2023, The GA4GH regulatory and ethics work stream (rews) at 10: An interdisciplinary, participative approach to international policy development in genomics, 13
  20. Precision Medicine, 2024, AI-driven precision medicine gains momentum in 2024. Precision medicine, Online
  21. The Australian, 2024, Magic Medicine? The Revolution in Genes and Health
  22. The Atlantic, 2024, The most Important Breakthroughs of 2024

Cited by

See all 30

Metadata

Authors
Abbas, S. R., Abbas, Z., Zahir, A., & Lee, S. W.
Affiliations
  • Sungkyunkwan University (KR)
  • Incheon National University (KR)
  • Kangbuk Samsung Hospital (KR)
Corresponding author
Lee, Seung Won
Venue
Briefings in Bioinformatics
Published
2025-07
Volume
26
Issue
4
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W4412487264
Cited by
30
References
133
Citations by year
2026: 20 · 2025: 10
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • Briefings in Bioinformatics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
rare genetic disorders, machine learning, deep learning, ensemble methods, disease classification, treatment optimization, biomarker discovery, genomic data security, data breaches, explainable machine learning, genomic data sharing, ethical considerations
MeSH terms
Machine Learning, Humans, Genome, Human, Genomics, Genetic Diseases, Inborn, Rare Diseases, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.